Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition
Apply
Rilzabrutinib, Digoxin, Rosuvastatin
An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step